These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24810337)

  • 41. A Prime/Boost Vaccine Regimen Alters the Rectal Microbiome and Impacts Immune Responses and Viremia Control Post-Simian Immunodeficiency Virus Infection in Male and Female Rhesus Macaques.
    Musich T; Thovarai V; Venzon DJ; Mohanram V; Tuero I; Miller-Novak LK; Helmold Hait S; Rahman MA; Hunegnaw R; Huiting E; Yuan W; O'hUigin C; Hoang T; Sui Y; LaBranche C; Montefiori D; Bear J; Rosati M; Bissa M; Berzofsky JA; Pavlakis GN; Felber BK; Franchini G; Robert-Guroff M
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preexisting vaccinia virus immunity decreases SIV-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA/MVA vaccine.
    Kannanganat S; Nigam P; Velu V; Earl PL; Lai L; Chennareddi L; Lawson B; Wilson RL; Montefiori DC; Kozlowski PA; Moss B; Robinson HL; Amara RR
    J Immunol; 2010 Dec; 185(12):7262-73. PubMed ID: 21076059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The kinetics of specific immune responses in rhesus monkeys inoculated with live recombinant BCG expressing SIV Gag, Pol, Env, and Nef proteins.
    Leung NJ; Aldovini A; Young R; Jarvis MA; Smith JM; Meyer D; Anderson DE; Carlos MP; Gardner MB; Torres JV
    Virology; 2000 Mar; 268(1):94-103. PubMed ID: 10683331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses.
    Lai L; Kwa SF; Kozlowski PA; Montefiori DC; Nolen TL; Hudgens MG; Johnson WE; Ferrari G; Hirsch VM; Felber BK; Pavlakis GN; Earl PL; Moss B; Amara RR; Robinson HL
    Vaccine; 2012 Feb; 30(9):1737-45. PubMed ID: 22178526
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal Challenge.
    Tuero I; Mohanram V; Musich T; Miller L; Vargas-Inchaustegui DA; Demberg T; Venzon D; Kalisz I; Kalyanaraman VS; Pal R; Ferrari MG; LaBranche C; Montefiori DC; Rao M; Vaccari M; Franchini G; Barnett SW; Robert-Guroff M
    PLoS Pathog; 2015 Aug; 11(8):e1005101. PubMed ID: 26267144
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cellular immunity elicited by human immunodeficiency virus type 1/ simian immunodeficiency virus DNA vaccination does not augment the sterile protection afforded by passive infusion of neutralizing antibodies.
    Mascola JR; Lewis MG; VanCott TC; Stiegler G; Katinger H; Seaman M; Beaudry K; Barouch DH; Korioth-Schmitz B; Krivulka G; Sambor A; Welcher B; Douek DC; Montefiori DC; Shiver JW; Poignard P; Burton DR; Letvin NL
    J Virol; 2003 Oct; 77(19):10348-56. PubMed ID: 12970419
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-lasting humoral and cellular immune responses and mucosal dissemination after intramuscular DNA immunization.
    Patel V; Valentin A; Kulkarni V; Rosati M; Bergamaschi C; Jalah R; Alicea C; Minang JT; Trivett MT; Ohlen C; Zhao J; Robert-Guroff M; Khan AS; Draghia-Akli R; Felber BK; Pavlakis GN
    Vaccine; 2010 Jul; 28(30):4827-36. PubMed ID: 20451642
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Replicating Adenovirus-SIV Immunization of Rhesus Macaques Induces Mucosal Dendritic Cell Activation and Function Leading to Rectal Immune Responses.
    Ko EJ; Helmold Hait S; Enyindah-Asonye G; Rahman MA; Hoang T; Robert-Guroff M
    Front Immunol; 2019; 10():779. PubMed ID: 31031768
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunogenicity of a vaccine regimen composed of simian immunodeficiency virus DNA, rMVA, and viral particles administered to female rhesus macaques via four different mucosal routes.
    Manrique M; Kozlowski PA; Cobo-Molinos A; Wang SW; Wilson RL; Montefiori DC; Carville A; Aldovini A
    J Virol; 2013 Apr; 87(8):4738-50. PubMed ID: 23408627
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine.
    Sparger EE; Dubie RA; Shacklett BL; Cole KS; Chang WL; Luciw PA
    Virology; 2008 May; 374(2):261-72. PubMed ID: 18261756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge.
    Reynolds MR; Weiler AM; Piaskowski SM; Piatak M; Robertson HT; Allison DB; Bett AJ; Casimiro DR; Shiver JW; Wilson NA; Lifson JD; Koff WC; Watkins DI
    Vaccine; 2012 Jun; 30(30):4465-75. PubMed ID: 22569124
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Analysis of humoral immune responses in rhesus macaques vaccinated with attenuated SIVmac239Deltanef and challenged with pathogenic SIVmac251.
    Freissmuth D; Hiltgartner A; Stahl-Hennig C; Fuchs D; Tenner-Racz K; Racz P; Uberla K; Strasak A; Dierich MP; Stoiber H; Falkensammer B
    J Med Primatol; 2010 Apr; 39(2):97-111. PubMed ID: 20015159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protective immunity to SIV challenge elicited by vaccination of macaques with multigenic DNA vaccines producing virus-like particles.
    Mossman SP; Pierce CC; Watson AJ; Robertson MN; Montefiori DC; Kuller L; Richardson BA; Bradshaw JD; Munn RJ; Hu SL; Greenberg PD; Benveniste RE; Haigwood NL
    AIDS Res Hum Retroviruses; 2004 Apr; 20(4):425-34. PubMed ID: 15157361
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Better protective effects in rhesus macaques by combining systemic and mucosal application of a dual component vector vaccine after rectal SHIV89.6P challenge compared to systemic vaccination alone.
    Stolte-Leeb N; Bieler K; Kostler J; Heeney J; Haaft PT; Suh YS; Hunsmann G; Stahl-Hennig C; Wagner R
    Viral Immunol; 2008 Jun; 21(2):235-46. PubMed ID: 18476770
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques.
    McDermott AB; O'Connor DH; Fuenger S; Piaskowski S; Martin S; Loffredo J; Reynolds M; Reed J; Furlott J; Jacoby T; Riek C; Dodds E; Krebs K; Davies ME; Schleif WA; Casimiro DR; Shiver JW; Watkins DI
    J Virol; 2005 Dec; 79(24):15556-66. PubMed ID: 16306626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evolution of envelope-specific antibody responses in monkeys experimentally infected or immunized with simian immunodeficiency virus and its association with the development of protective immunity.
    Cole KS; Rowles JL; Jagerski BA; Murphey-Corb M; Unangst T; Clements JE; Robinson J; Wyand MS; Desrosiers RC; Montelaro RC
    J Virol; 1997 Jul; 71(7):5069-79. PubMed ID: 9188572
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Persistent Low-Level Replication of SIVĪ”nef Drives Maturation of Antibody and CD8 T Cell Responses to Induce Protective Immunity against Vaginal SIV Infection.
    Adnan S; Reeves RK; Gillis J; Wong FE; Yu Y; Camp JV; Li Q; Connole M; Li Y; Piatak M; Lifson JD; Li W; Keele BF; Kozlowski PA; Desrosiers RC; Haase AT; Johnson RP
    PLoS Pathog; 2016 Dec; 12(12):e1006104. PubMed ID: 27959961
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Live, attenuated simian immunodeficiency virus SIVmac-M4, with point mutations in the Env transmembrane protein intracytoplasmic domain, provides partial protection from mucosal challenge with pathogenic SIVmac251.
    Shacklett BL; Shaw KE; Adamson LA; Wilkens DT; Cox CA; Montefiori DC; Gardner MB; Sonigo P; Luciw PA
    J Virol; 2002 Nov; 76(22):11365-78. PubMed ID: 12388697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An SAMT-247 Microbicide Provides Potent Protection against Intravaginal Simian Immunodeficiency Virus Infection of Rhesus Macaques, whereas an Added Vaccine Component Elicits Mixed Outcomes.
    Helmold Hait S; Hogge CJ; Rahman MA; Ko EJ; Hunegnaw R; Mushtaq Z; Enyindah-Asonye G; Hoang T; Miller Jenkins LM; Appella E; Appella DH; Robert-Guroff M
    J Immunol; 2020 Jun; 204(12):3315-3328. PubMed ID: 32393514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SIV antigen-specific effects on immune responses induced by vaccination with DNA electroporation and plasmid IL-12.
    Lindsay RW; Ouellette I; Arendt HE; Martinez J; DeStefano J; Lopez M; Pavlakis GN; Chiuchiolo MJ; Parks CL; King CR
    Vaccine; 2013 Oct; 31(42):4749-58. PubMed ID: 23954384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.